J. Bezin, M. Duong, R. Lassalle, C. Droz, A. Pariente et al., The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology, Pharmacoepidemiol Drug Saf, vol.26, issue.8, pp.954-62, 2017.

. , 41 du 26 janvier 2016 de modernisation de notre système de santé, 2016.

, Arrêté du 22 mars 2017 relatif au référentiel de sécurité applicable au Système national des données de santé

G. Rey, Les données des certificats de décès en France : processus deproduction et principaux types d'analyse, Rev Med Interne, vol.37, issue.10, pp.685-93, 2016.
DOI : 10.1016/j.revmed.2016.01.011

E. Drezen, T. Guyet, and A. Happe, From medico-administrative databases analysis to care trajectories analytics: an example with the French SNDS, Fundam Clin Pharmacol, vol.32, issue.1, pp.78-80, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01631802

A. Happe and E. Drezen, A visual approach of care pathways from the French nationwide SNDS database-from population to individual records: the ePEPS toolbox, Fundam Clin Pharmacol, vol.32, issue.1, pp.81-85, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01697626

E. Polard, E. Nowak, A. Happe, A. Biraben, E. Oger et al., Brand name to generic substitution of antiepileptic drugs does not lead to seizure-related hospitalization: a population-based case-crossover study, Pharmacoepidemiol Drug Saf, vol.24, issue.11, pp.1161-1170, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01269917

J. Bezin, A. Pariente, R. Lassalle, C. Dureau-pournin, A. Abouelfath et al., Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France, Eur J Clin Pharmacol, vol.70, issue.4, pp.429-465, 2014.

F. Montastruc, A. Bénard-laribière, P. Noize, E. Pambrun, F. Diaz-bazin et al., Antipsychotics use: 2006-2013 trends in prevalence and incidence and characterization of users, Eur J Clin Pharmacol, vol.74, issue.5, pp.619-645, 2018.

G. Moulis, M. Lapeyre-mestre, A. Palmaro, G. Pugnet, J. Montastruc et al., French health insurance databases: What interest for medical research, Rev Med Interne, vol.36, issue.6, pp.411-418, 2015.
DOI : 10.1016/j.revmed.2014.11.009
URL : https://doi.org/10.1016/j.revmed.2014.11.009

S. N. Murphy, M. E. Mendis, D. A. Berkowitz, I. Kohane, and H. C. Chueh, Integration of clinical and genetic data in the i2b2 architecture, AMIA Annu Symp Proc AMIA Symp, 1040.

S. N. Murphy, G. Weber, M. Mendis, V. Gainer, H. C. Chueh et al., Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2), J Am Med Inform Assoc JAMIA, vol.17, issue.2, pp.124-154, 2010.

G. Hripcsak, J. D. Duke, N. H. Shah, C. G. Reich, V. Huser et al., Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers, Studies in Health Technology and Informatics, pp.574-582, 2015.

M. Cuggia, N. Garcelon, B. Campillo-gimenez, T. Bernicot, J. Laurent et al.,

, Roogle: an information retrieval engine for clinical data warehouse, Stud Health Technol Inform, vol.169, pp.584-592, 2011.

N. Garcelon, A. Neuraz, R. Salomon, H. Faour, V. Benoit et al., A clinician friendly data warehouse oriented toward narrative reports: Dr. Warehouse, J Biomed Inform
DOI : 10.1016/j.jbi.2018.02.019

D. Delamarre, G. Bouzille, K. Dalleau, D. Courtel, and M. Cuggia, Semantic integration of medication data into the EHOP Clinical Data Warehouse. Stud Health Technol Inform, 2015.

S. B. Williams, J. Huo, K. Chamie, M. C. Smaldone, C. D. Kosarek et al.,

, Discerning the survival advantage among patients with prostate cancer who undergo radical prostatectomy or radiotherapy: The limitations of cancer registry data, Cancer, vol.123, issue.9, pp.1617-1641, 2017.

M. Roach, Re: Morbidity and Mortality of Locally Advanced Prostate Cancer: A Population Based Analysis Comparing Radical Prostatectomy Versus External Beam Radiation, Eur Urol, vol.73, issue.4, pp.638-647, 2018.

M. Zins, M. Goldberg, C. Constances-team-;-l,-carette, C. Rives-lange, J. Matta et al., The French CONSTANCES populationbased cohort: design, inclusion and follow-up, Feral-Pierssens A, vol.30, issue.12, p.194831, 2015.
DOI : 10.1007/s10654-015-0096-4
URL : http://europepmc.org/articles/pmc4690834?pdf=render

B. Merle, G. Moreau, A. Ozguler, B. Srour, A. Cougnard-grégoire et al., Unhealthy behaviours and risk of visual impairment: The CONSTANCES population-based cohort. Sci Rep, vol.8, p.6569, 2018.

E. Wiernik, P. Meneton, J. Empana, J. Siemiatycki, N. Hoertel et al.,

, Cardiovascular risk goes up as your mood goes down: Interaction of depression and socioeconomic status in determination of cardiovascular risk in the CONSTANCES cohort, Int J Cardiol, vol.262, pp.99-105, 2018.

G. Earle-richardson, M. Scribani, E. Scott, J. May, and P. Jenkins, A comparison of health, health behavior, and access between farm and nonfarm populations in rural New York state, J Rural Health Off J Am Rural Health Assoc Natl Rural Health Care Assoc, vol.31, issue.2, pp.157-64, 2015.

K. E. Deligiannidis, Primary Care Issues in Rural Populations. Prim Care, 2017.

L. Scailteux, S. Vincendeau, F. Balusson, C. Leclercq, A. Happe et al., Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists-a nationwide population-based cohort study based on 20102013 French Health Insurance data, Eur J Cancer, vol.77, pp.99-108, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02051031

L. Scailteux, F. Balusson, S. Vincendeau, N. Rioux-leclercq, and E. Nowak, Rationale and design of the CANARI study: a case-control study investigating the association between prostate cancer and 5-alpha-reductase inhibitors for symptomatic benign prostate hypertrophy by linking SNIIRAM and pathology laboratories in a specific region in France, Fundam Clin Pharmacol, vol.32, issue.1, pp.120-129, 2018.

L. Scailteux, N. Rioux-leclercq, S. Vincendeau, F. Balusson, E. Nowak et al., Use of 5?-reductase inhibitors for benign prostate hypertrophy and risk of high grade prostate cancer: a French population-based study, BJU Int, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01863270

T. Arnason, P. S. Wells, C. Walraven, . Van, and A. J. Forster, Accuracy of coding for possible warfarin complications in hospital discharge abstracts, Thromb Res, vol.118, issue.2, pp.253-62, 2006.

F. Pisa, J. Castellsague, D. Drigo, N. Riera-guardia, M. Giangreco et al., Accuracy of International Classification of Diseases, 9th Revision, Clinical Modification codes for upper gastrointestinal complications varied by position and age: a validation study in a cohort of nonsteroidal anti-inflammatory drugs users in Friuli Venezia Giulia, Italy. Pharmacoepidemiol Drug Saf, vol.22, issue.11, pp.1195-204, 2013.

T. Delate, A. E. Jones, N. P. Clark, and D. M. Witt, Assessment of the coding accuracy of warfarin-related bleeding events, Thromb Res, vol.159, pp.86-90, 2017.

G. Maura, P. Blotière, K. Bouillon, C. Billionnet, P. Ricordeau et al., Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study, Circulation, vol.132, issue.13, pp.1252-60, 2015.

E. R. Weeda, C. M. White, W. F. Peacock, and C. I. Coleman, Rates of major bleeding with rivaroxaban in real-world studies of nonvalvular atrial fibrillation patients: a meta-analysis, Curr Med Res Opin, vol.32, issue.6, pp.1117-1137, 2016.

C. Droitcourt, E. Nowak, C. Rault, L. Nautout, B. Happe et al., Risk of suicide attempt associated with isotretinoin: a nationwide cohort and case-time-control study, pp.15-16, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02150353

C. Droitcourt, E. Nowak, C. Rault, A. Happe, L. Nautout et al., Le risque suicidaire est-il majoré sous isotrétinoïne ? Analyse des données nationales de l'assurance maladie, SNIIRAM 2009-2016)-Journées Dermatologiques de, vol.144, p.58, 2017.

L. Josseran, A. Fouillet, N. Caillère, D. Brun-ney, D. Ilef et al., Assessment of a syndromic surveillance system based on morbidity data: results from the Oscour network during a heat wave, PloS One, vol.5, issue.8, p.11984, 2009.

C. Damase-michel, I. Lacroix, C. Hurault-delarue, A. Beau, J. Montastruc et al., Évaluation des médicaments chez la femme enceinte : à propos de la base de données française EFEMERIS, Therapie, vol.69, issue.1, pp.91-100, 2014.

C. Hurault-delarue, I. Lacroix, A. Bénard-laribière, J. Montastruc, A. Pariente et al., Antidepressants during pregnancy: a French drug utilisation study in EFEMERIS cohort, Eur Arch Psychiatry Clin Neurosci, 2018.

A. Beau, A. Didier, C. Hurault-delarue, J. Montastruc, I. Lacroix et al., Prescription of asthma medications before and during pregnancy in France: An observational drug study using the EFEMERIS database, J Asthma Off J Assoc Care Asthma, vol.54, issue.3, pp.258-64, 2017.

C. Hurault-delarue, C. Damase-michel, L. Finotto, C. Guitard, C. Vayssière et al., Psychomotor developmental effects of prenatal exposure to psychotropic drugs: a study in EFEMERIS database, Fundam Clin Pharmacol, vol.30, issue.5, pp.476-82, 2016.

A. Beau, M. Tauber, C. Chollet, C. Hurault-delarue, C. Bouilhac et al., A contemporary description of French newborns' growth using the Efemeris cohort. Arch Pediatr Organe Off Soc Francaise Pediatr, vol.24, pp.424-455, 2017.

L. Palosse-cantaloube, C. Hurault-delarue, A. Beau, J. Montastruc, I. Lacroix et al., Risk of infections during the first year of life after in utero exposure to drugs acting on immunity: A population-based cohort study, Pharmacol Res, vol.113, pp.557-62, 2016.

E. Oger, Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale, Thromb Haemost, vol.83, issue.5, pp.657-60, 2000.
URL : https://hal.archives-ouvertes.fr/hal-00726218

T. J. Murtola, T. Tammela, L. Määttänen, M. Ala-opas, U. H. Stenman et al.,

, Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial, Br J Cancer, vol.101, issue.5, pp.843-851, 2009.

D. Robinson, H. Garmo, A. Bill-axelson, L. Mucci, L. Holmberg et al., Use of 5?reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study, JAMA Intern Med, vol.346, 2013.

. Scailteux,

, Thérapie, vol.174, issue.8, pp.1301-1308

B. Yavuz, M. Ayturk, S. Ozkan, M. Ozturk, C. Topaloglu et al., A real world data of dabigatran etexilate: multicenter registry of oral anticoagulants in nonvalvular atrial fibrillation, J Thromb Thrombolysis, vol.42, issue.3, pp.399-404, 2016.

C. Becattini, L. Franco, J. Beyer-westendorf, L. Masotti, C. Nitti et al., Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life, Int J Cardiol, vol.227, pp.261-267, 2017.

Y. Xu, S. Schulman, D. Dowlatshahi, A. M. Holbrook, C. S. Simpson et al.,

, Direct Oral Anticoagulant-or Warfarin-Related Major Bleeding: Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational Study, Chest, vol.152, issue.1, pp.81-91, 2017.

T. B. Larsen, F. Skjøth, J. N. Kjaeldgaard, G. Lip, P. B. Nielsen et al., Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study, Lancet Haematol, vol.4, issue.5, pp.237-281, 2017.

A. Sundström, L. Alfredsson, G. Sjölin-forsberg, B. Gerdén, U. Bergman et al., Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study, BMJ, vol.341, p.5812, 2010.

A. Carrère, Les enrichissements prévus pour l'enquête CARE-Ménages. Direction de la recherche, des études, de l'évaluation et des statistiques, 2017.

J. Bezin, P. Girodet, S. Rambelomanana, M. Touya, P. Ferreira et al., Choice of ICD-10 codes for the identification of acute coronary syndrome in the French hospitalization database, Fundam Clin Pharmacol, vol.29, issue.6, pp.586-91, 2015.

L. Sahli, M. Lapeyre-mestre, H. Derumeaux, and G. Moulis, Positive predictive values of selected hospital discharge diagnoses to identify infections responsible for hospitalization in the French national hospital database, Pharmacoepidemiol Drug Saf, vol.25, issue.7, pp.785-794, 2016.

M. Prat, H. Derumeaux, L. Sailler, M. Lapeyre-mestre, and G. Moulis, Positive predictive values of peripheral arterial and venous thrombosis codes in French hospital database, Fundam Clin Pharmacol, vol.32, issue.1, pp.108-121, 2018.

D. H. Lawson, V. Sherman, and J. Hollowell, The General Practice Research Database, QJM Mon J Assoc Physicians, vol.91, issue.6, pp.445-52, 1998.

J. Perlbarg, C. Allonier, P. Boisnault, F. Daniel, L. Fur et al., Faisabilité et intérêt de l'appariement de données individuelles en médecine générale et de données de remboursement appliqué au diabète et à l'hypertension artérielle. Sante Publique Vandoeuvre-Nancy Fr, vol.26, pp.355-63, 2014.

J. M. Unger, D. L. Hershman, C. Till, C. M. Tangen, W. E. Barlow et al.,

, Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial, J Natl Cancer Inst, 2009.

I. M. Thompson, P. J. Goodman, C. M. Tangen, M. S. Lucia, G. J. Miller et al., The influence of finasteride on the development of prostate cancer, N Engl J Med, vol.17, issue.3, pp.215-239, 2003.

, Présentation de l'INDS | INDS Institut National des Données de Santé

, Nomination de Dominique POLTON en qualité de co-pilote du Health Data Hub |

, INDS Institut National des Données de Santé, 2018.

, Agnès Buzyn lance la mission de préfiguration du « Health Data Hub » un laboratoire d'exploitation des données de santé

. Ministère-des-solidarités and . De-la-santé, , 2018.